Generation Bio Co. (GBIO) Dividend History

Company News

• Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

  Generation Bio, a biotechnology company, announced that its president and CEO will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on August 13th, 2024.

  GlobeNewswire Inc.
• Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates

  Generation Bio (GBIO) delivered earnings and revenue surprises of -211.11% and 34.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: TSHA
• Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

  - Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP)

  GlobeNewswire Inc.
• Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

  CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting preclinical data from its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms have been accepted for presentation, including one oral presentation, at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place May 7-11, 2024 in Baltimore, MD.

  GlobeNewswire Inc.
• Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates

  Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -29.27% and 5.64%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: SLGL